Webinar: Five Ways to Control Your Critical Antibody Reagents and Avoid Bioanalytical Assay Failure

Follow us on:

Facebook X Linkedin YouTube Pinterest WeChat

The success of a bioanalytical ligand binding assay is significantly impacted by antibody quality. Using poorly characterized and controlled reagents can result in having to spend extra time reworking your assay or doing multiple validations, and can affect the translatability of data between phases.

Listen to this webinar to get insights into how to secure high quality, reproducible, and sustainable critical antibody reagents early in the development lifecycle, and avoid the frustrations and risks associated with assay development failure.

You will learn:

  • The importance of sourcing high quality antibodies for ligand binding assays
  • How a custom antibody can be designed specifically for your assay
  • How conjugation can be controlled using SpyTag technology
  • Key assays for characterizing antibody reagents
  • How recombinant antibodies offer reproducibility and sustainability

This webinar is recommended for scientists seeking custom antibody reagents designed to target a large molecule biologic or biosimilar, and suitable for the development of pharmacokinetic and anti-drug antibody ligand binding assays.

Webinar: Five Ways to Control Your Critical Antibody Reagents and Avoid Bioanalytical Assay Failure

Presented by: Dr Paul Royle, Technical Sales Manager, Bio-Rad Laboratories


Speaker Biography:

Dr Paul Royle, Technical Sales Manager, Bio-Rad LaboratoriesPaul Royle is the Technical Sales Manager for Bio-Rad’s Custom Antibody Service and has been with Bio-Rad’s antibody division for over 7 years. Prior to this, he worked in an immunology diagnostics company for almost 7 years. Paul holds a degree and PhD from the University of Nottingham (UK), and has post-doctoral research experience from the University of Warwick (UK).


Resources

TrailBlazer Antibody Custom Services
 

Get more details about SpyTag technology, how it works with our antibody generation service, and see data for different experimental applications.